Search Within

Jedd D Wolchok

Formats
  1. Journal Article (450)
  2. Meeting Abstract (414)
  3. Book Section (19)
  4. Editorial (9)
  5. Review (5)
  6. Correspondence (3)
  7. Research Letter (3)
  8. Book Whole (1)
  9. Conference Paper (1)
Groups
  1. Department of Medicine (905)
  2. GSK Faculty (905)
  3. Melanoma and Immunotherapeutics Service (905)
  4. Solid Tumor Oncology Division (905)
  5. Melanoma Disease Management Team (222)
  6. Sloan Kettering Institute Postdocs (195)

More Groups

People
  1. Taha Merghoub (230)
  2. Michael Postow (158)
  3. Alan Houghton (118)
  4. Margaret Callahan (113)
  5. Paul Chapman (107)
  6. Katherine Panageas (92)

More People

Years
  1. 2024 (2)
  2. 2023 (15)
  3. 2022 (46)
  4. 2021 (42)
  5. 2020 (46)
  6. 2019 (47)

More Years

Publications
  1. Journal of Clinical Oncology (171)
  2. Journal for ImmunoTherapy of Cancer (81)
  3. Cancer Research (59)
  4. Clinical Cancer Research (35)
  5. Annals of Oncology (34)
  6. European Journal of Cancer (23)

More Publications

Publishers
  1. American Society of Clinical Oncology (171)
  2. American Association for Cancer Research (130)
  3. Biomed Central Ltd (83)
  4. Elsevier Inc. (70)
  5. Nature Publishing Group (52)
  6. Oxford University Press (44)

More Publishers

Results (905)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • GITR pathway activation abrogates tumor immune suppression through loss of regulatory T-cell lineage stability
    Journal Article

    Schaer, D. A.; Budhu, S.; Liu, C.; Bryson, C.; Malandro, N.; Cohen, A.; Zhong, H.; Yang, X.; Houghton, A. N.; Merghoub, T.; more...
    Cancer Immunology Research (2013)

    Fulltext@MSK | Save
  • Increased frequency of ICOS+ CD4 T cells as a pharmacodynamic biomarker for anti-CTLA-4 therapy
    Journal Article

    Tang, D. N.; Shen, Y.; Sun, J. J.; Wen, S. J.; Wolchok, J. D.; Yuan, J. D.; Allison, J. P.; Sharma, P.
    Cancer Immunology Research (2013)

    Fulltext@MSK | Save
  • Enhancement of tumor-reactive cytotoxic CD4(+) T-cell responses after ipilimumab treatment in four advanced melanoma patients
    Journal Article

    Kitano, S.; Tsuji, T.; Liu, C.; Hirschhorn-Cymerman, D.; Kyi, C.; Mu, Z.; Allison, J. P.; Gnjatic, S.; Yuan, J. D.; Wolchok, J. D.
    Cancer Immunology Research (2013)

    Fulltext@MSK | Save
  • A pilot study of preoperative (Pre-op), single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early-stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Solomon, S. B.; Comstock, C.; Maybody, M.; Sacchini, V.; Durack, J. C.; Blum, B.; Yuan, J. D.; Patil, S.; Neville, D. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM)
    Meeting Abstract

    Carvajal, R. D.; Sosman, J. A.; Quevedo, F.; Milhem, M. M.; Joshua, A. M.; Kudchadkar, R. R.; Linette, G. P.; Gajewski, T.; Lutzky, J.; Lawson, D. H.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244) in patients with BRAFV600E/K- or NRAS-mutated melanoma
    Meeting Abstract

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Combined nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab in the treatment of advanced melanoma (MEL) patients (pts): Safety and clinical activity
    Meeting Abstract

    Sznol, M.; Callahan, M. K.; Kluger, H.; Postow, M. A.; Burke, M.; Hong, Q.; Selby, M.; Korman, A.; Gupta, A.; Wolchok, J. D.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Phase I trial evaluating concurrent vemurafenib and ipilimumab in patients with advanced BRAF-mutant melanoma
    Meeting Abstract

    Ribas, A.; Hodi, F. S.; Callahan, M.; Chmielowski, B.; Lawrence, D.; Konto, C.; McHenry, M. B.; Choong, N.; Wolchok, J.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Survival analysis with 5 years of follow-up in a phase III study of ipilimumab and dacarbazine in metastatic melanoma
    Meeting Abstract

    Maio, M.; Bondarenko, I.; Robert, C.; Thomas, L.; Garbe, C.; Testori, A.; Lu, H.; Chin, K.; Wolchok, J.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • MEDI4736, an anti-PD-L1 antibody with modified Fc domain: Preclinical evaluation and early clinical results from a phase 1 study in patients with advanced solid tumors
    Meeting Abstract

    Khleif, S.; Lutzky, J.; Segal, N.; Antonia, S.; Blake-Haskins, A.; Stewart, R.; Robbins, P.; Shalabi, A.; Ibrahim, R.; Wolchok, J.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save